rethinking how we secure and value antibiotics for the future

Thursday 10th September 2020 

London | 12:00–13:30 (GMT+1)
Paris | 13:00–14:30 (GMT+2)
New York | 07:00–08:30 (GMT-4)

Against the backdrop of global pandemics, join us for a live virtual event where we are convening a world-class panel to discuss pressing issues created by the increasing emergence and spread of antimicrobial resistance. Emphasising recognition of the full value of anti-infectives, this event will encourage debate and stimulate ideas on how our much-needed individual and collective action can transform the current environment to ensure that effective anti-infective treatments are in place to enable and secure modern medicine.


Professor Dame Sally Davies

UK Special Envoy on Antimicrobial Resistance, London, UK

Dr Christine Årdal

Co-Lead, Research and Innovation, EU Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections, Norway

Dr Nick Crabb

Programme Director, Scientific Affairs, National Institute for Health and Care Excellence, Manchester, UK

Dr John Rex

Chief Medical Officer and Director, F2G Ltd, Manchester, UK; Operating Partner, Advent Life Sciences, London, UK

Professor Mark Wilcox

Consultant Medical Microbiologist, Head of Microbiology Research & Development and NIHR Diagnostic Cooperative Infection Lead, Leeds Teaching Hospitals NHS Trust, UK; Professor of Medical Microbiology, University of Leeds, UK

Register Today
Please enter your information to register for this webinar.

First Name:
Last Name:
Email Address:
Privacy Policy: Privacy Information Your personal data that you provide to us will be processed by Pfizer for the purpose of managing your attendance at the AMR Live Virtual Event. We will share your personal data with Synergy and American Meetings Inc. who manage our meeting registration website and is under an obligation to process your personal data only for that purpose. To find out more about how Pfizer processes your personal data, including public disclosures of the transfers of value that you may receive from Pfizer, please refer to the Pfizer Privacy Notice at If you have questions about our Privacy Notice, or if you would like to exercise any individual rights for example to review, correct, update, suppress, restrict or delete personal data that you have provided to us, or to opt out of any communications, please contact us at, or write to the following address: Pfizer Limited, IPC 1-1, Walton Oaks, Dorking Road, Tadworth, Surrey KT20 7NS.
Adverse events should be reported. Reporting forms and information can be found at yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

Terms and Conditions

Privacy Policy
August 2020
Additional Information©Pfizer Inc. 2020 All rights reserved.